4//SEC Filing
Hall Susan 4
Accession 0000885590-12-000062
CIK 0000885590other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 3:29 PM ET
Size
5.3 KB
Accession
0000885590-12-000062
Insider Transaction Report
Form 4
Hall Susan
Global Head of R&D
Transactions
- Tax Payment
Common Stock, no par values
2012-10-04−8,672→ 13,424 total
Footnotes (2)
- [F1]This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Performance Share Units on September 26, 2012.
- [F2]This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001542052
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 3:29 PM ET
- Size
- 5.3 KB